About US
Contact us
-
FDA approves Boehringer Ingelheim's Pradaxa for stroke risk reduction in patients with non-valvular AFFDA approves Boehringer Ingelheim's Pradaxa for stroke risk reduction in patients with non-valvular AF The US Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate), B2010/10/21
-
Pfizer enters partnership with Teuto to develop, commercialize generic medicinesPfizer enters partnership with Teuto to develop, commercialize generic medicines Pfizer Inc. (NYSE: PFE) announced today that it is entering into a partnership with Laboratorio Teuto Brasileiro S.2010/10/21
-
SFDA Deputy Commissioner Bian Zhenjia attends the opening ceremony of Sino-Swedish SymbioCare Forum in ShanghaiSFDA Deputy Commissioner Bian Zhenjia attends the opening ceremony of Sino-Swedish SymbioCare Forum in Shanghai On October 13, 2010, Bian Zhenjia, Deputy Commissioner of the State Food and Drug Ad2010/10/20
-
Long-term use of statins reduces colorectal cancer riskLong-term use of statins reduces colorectal cancer risk A systematic review of the medical literature supports the hypothesis that statins, cholesterol-lowering drugs used to prevent cardiac probl2010/10/20
-
FDA approves Teva's generic Prevacid SoluTab ANDAFDA approves Teva's generic Prevacid SoluTab ANDA Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted approval for the Company2010/10/19
-
SFDA further specifies the application acceptance of administrative licensing for cosmeticsSFDA further specifies the application acceptance of administrative licensing for cosmetics To strengthen the application acceptance of administrative licensing for cosmetics and further standardi2010/10/19
-
Bristol-Myers, Otsuka launch My SPRYCEL Support program to assist patients with CMLBristol-Myers, Otsuka launch My SPRYCEL Support program to assist patients with CML Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. today announced the launch of My SP2010/10/18
-
Questcor's H.P. Acthar Gel sNDA for infantile spasms receives FDA approvalQuestcor's H.P. Acthar Gel sNDA for infantile spasms receives FDA approval Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced the U.S. Food and Drug Administration (FDA) has approved Qu2010/10/18
-
GSK to expand donation of albendazole medicine to treat children with STH riskGSK to expand donation of albendazole medicine to treat children with STH risk At the launch of the World Health Organization's (WHO) first report on Neglected Tropical Diseases today, GSK announc2010/10/15
-
SFDA issues Requirements on Application Dossiers in CTD Format for Pharmaceutical ProductsSFDA issues Requirements on Application Dossiers in CTD Format for Pharmaceutical Products In order to improve the quality and level of drug research and development of China and to be in line wit2010/10/15